Scinovex
article Open Access

Therapeutic management of theileriosis in cross-bred cattle

Journal of Entomology and Zoology Studies · 2020 · Vol. 8(3) · pp. 429–431

Abstract

Blood sample was collected from the affected animal for the presence of suspected haemoprotozoan infection and to record the haematological status. Blood smear examination revealed presence of Theileria annulata infection. Crossbred cattle was treated with Buparvaquone at dose rate of 2.5 mg/kg body weight intramuscularly and repeated after 7 days along with supportive therapy. After treatment, the clinical signs disappeared and animal health status improved. The observation showed successful treatment of the animal.

Vector-borne infectious diseasesInsect and Pesticide ResearchVector-Borne Animal DiseasesCrossbreedVeterinary medicineMedicineBlood smearBody weightAnimal healthBlood countAnimal scienceBiologyInternal medicine
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
8%
vs. same field & year
Related articles
Efficacy of buparavaquone in the treatment of bovine benign theileriosis
International Journal of Chemical Studies · 2018 · 0 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.